Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
15 studies found for:    "Syndrome of inappropriate antidiuretic hormone"
Show Display Options
Rank Status Study
1 Completed
Has Results
A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Condition: Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Intervention: Drug: tolvaptan
2 Completed Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Inappropriate ADH Syndrome;   Hyponatremia
Intervention: Drug: SR121463B
3 Completed Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Inappropriate ADH Syndrome;   Hyponatremia
Intervention: Drug: SR121463B
4 Completed Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Syndrome of Inappropriate ADH (SIADH) Secretion;   Hyponatremia
Intervention: Drug: satavaptan (SR121463B)
5 Withdrawn Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine
Condition: Syndrome of Inappropriate ADH-secretion
Intervention: Procedure: fluid restriction for 14 days (15ml fluid per kg weight)
6 Terminated A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia
Conditions: Hyponatremia;   Inappropriate ADH Syndrome
Interventions: Drug: Satavaptan;   Drug: placebo
7 Completed Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study
Condition: Inappropriate ADH Syndrome
Interventions: Other: Induced hypotonic hyponatremia - SIAD model;   Drug: Empagliflozin 25mg Tbl;   Drug: Placebo P-Tablet
8 Completed An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain
Conditions: Hyponatremia;   Syndrome of Inappropriate ADH (SIADH) Secretion
Intervention:
9 Completed An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH
Conditions: Hyponatremia;   Syndrome of Inappropriate ADH (SIADH) Secretion
Intervention:
10 Completed Subclassification of the Syndrome of Inappropriate ADH Secretion
Condition: Hyponatremia
Intervention:
11 Terminated
Has Results
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Conditions: Hyponatremia;   Dilutional Hyponatremia;   Inappropriate ADH Syndrome
Interventions: Drug: tolvaptan;   Other: Fluid Restriction
12 Recruiting An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy
Conditions: Hyponatremia;   Syndrome of Inappropriate ADH (SIADH) Secretion;   Cancer
Intervention:
13 Completed "SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
Conditions: Hyponatremia;   Water Intoxication;   Inappropriate ADH Syndrome;   Water-electrolyte Imbalance
Intervention: Drug: Tolvaptan
14 Completed “SALT Trial” Study of Ascending Levels of Tolvaptan in Hyponatremia
Conditions: Hyponatremias;   Water Intoxication;   Inappropriate ADH Syndrome;   Water-Electrolyte Imbalances
Intervention: Drug: tolvaptan
15 Enrolling by invitation Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study
Condition: SIADH
Interventions: Drug: Empagliflozin;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.